Parallel Advisors’s 1Life Healthcare ONEM Stock Holding History

Parallel Advisors’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-117,152	Closed	-$1.96M	–	3550
2022 Q4	$1.96M	Hold	117,152	–	–	0.08%	159
2022 Q3	$2.01M	Sell	117,152 -50,790	-30%	-$797K	0.09%	150
2022 Q2	$1.32M	Buy	167,942 +6,227	+4%	+$53.5K	0.06%	198
2022 Q1	$1.78M	Sell	161,715 -99	-0.1%	-$1.11K	0.07%	180
2021 Q4	$2.84M	Buy	161,814 +523	+0.3%	+$10.1K	0.11%	140
2021 Q3	$3.27M	Sell	161,291 -7,553	-4%	-$194K	0.13%	114
2021 Q2	$5.58M	Sell	168,844 -905	-0.5%	-$34.2K	0.24%	69
2021 Q1	$6.63M	Sell	169,749 -98,964	-37%	-$4.65M	0.31%	60
2020 Q4	$11.7M	Sell	268,713 -29,083	-10%	-$993K	0.64%	28
2020 Q3	$8.45M	Buy	+297,796	New	+$9.4M	0.52%	33

Parallel Advisors's ONEM Position: Q1 2023 in Review

Parallel Advisors sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 117,152 shares — an estimated $1.96M sold.

Parallel Advisors first reported a position in ONEM in Q3 2020 and held it in 10 quarters. The position peaked at $11.7M in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

Parallel Advisors reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
Parallel Advisors sold 117,152 1Life Healthcare shares in Q1 2023, an estimated $1.96M.
Parallel Advisors first reported a position in 1Life Healthcare in Q3 2020 and held it in 10 quarters.
Parallel Advisors's 1Life Healthcare position peaked at $11.7M in Q4 2020.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Parallel Advisors's 13F filing for Q1 2023, filed 25 Apr 2023.